Clinical Trials Browser

Phase 2 × Non-small Cell Lung Cancer Metastatic × Ramucirumab × Clear all

NCT04394624 2025-06-06

CARMEN-LC04

Phase 2 Terminated

31 enrolled 22 charts

Non-small Cell Lung Cancer Metastatic

NCT01703091 2019-09-30

A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer

Phase 2 Completed

197 enrolled 12 charts

Non-small Cell Lung Cancer Metastatic